Please use this identifier to cite or link to this item:
Title: Non-Invasive monitoring of Inflammatory Bowel Disease : time to use newer tools?
Authors: Azzopardi, Neville
Keywords: Colitis -- Diagnosis
Inflammatory Bowel Diseases -- Monitoring
C-Reactive Protein
Issue Date: 2013
Publisher: Malta Medical Journal
Citation: Malta Medical Journal. 2013, Vol.25(1), p. 36-40
Abstract: Introduction: In inflammatory bowel disease (IBD), commonly used biomarkers employed for non-invasive monitoring of disease activity are the C-reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR). Ulcerative colitis (UC) has a modest to absent CRP response despite active inflammation. Iron deficiency anaemia (IDA) is often a marker of active disease in IBD. Methods: CRP, ESR, and Haemoglobin level taken within 7 days of a colonoscopy were analysed and compared with histopathological findings from colonic and ileal biopsies. Results: Colonic biopsies from 95 colonoscopies in UC patients; and colonic and ileal biopsies from 98 colonoscopies in CD patients were analyzed. The Positive Predictive Values and Negative Predictive Values relating to ESR, CRP and iron deficiency anaemia in the two groups of patients were calculated. Conclusion: UC has a similar CRP response to CD in active inflammation. Commonly used biomarkers have poor sensitivities in demonstrating active mucosal disease. IDA has little value when used as a marker of disease activity on its own but may be used as an adjunct to ESR and CRP. Faecal biomarkers and novel antibodies may help to increase the sensitivity and specificity in non-invasive monitoring of IBD.
Appears in Collections:MMJ, Volume 25, Issue 1
MMJ, Volume 25, Issue 1
Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
2013.Vol25.Issue1.A7.pdfNon-Invasive monitoring of Inflammatory Bowel Disease: time to use newer tools?509.27 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.